Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
Pharmacists have always prescribed, but they have the potential to prescribe much moreManagement of apathy in patients with Alzheimer’s disease
People diagnosed with Alzheimer’s disease often experience symptoms of apathy, which can be treated by pharmacological and behavioural interventions.
The purpose of this evidence...
Remote Australians at increased risk for diabetes complications
Mortality rates are four times higher for Indigenous patients with diabetes than non-Indigenous Australians, a report has found.
The Australian Institute of Health and Welfare...
My Health Record – where to from here?
While the My Health Record (MHR) opt-out date of January 31 has come and gone, people still have the option to permanently delete their...
Rethinking how we manage osteoarthritis pain
Alex Page, pharmacist at Outback Pharmacies and former winner of the PSA Award for QUM in Pain Management, and Joyce McSwan, Founder and Managing...
Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
Medication adherence through community pharmacy intervention
Community pharmacist-led interventions have been shown to improve adherence and health outcomes for patients with chronic diseases but a number of barriers remain.
Researchers from...
